Moreover, Hdac2 knockdown and subchronic treatment with HDAC inhibitor suberoylanilide hydroxamic acid (SAHA) were sufficient to improve learning and memory in Tcf4+/− mice, thus indicating that cognition in PTHS model mice can be improved by HDAC inhibitors through normalization of synaptic plasticity. This evidence concerns the gene TCF4 and Pitt-Hopkins syndrome.